ACTIV Executive Committee
Co-Chairs
- Previous
- Francis Collins, National Institutes of Health (NIH)
- Paul Stoffels, Johnson & Johnson
Co-Chairs
- William Pao, Pfizer
- Lawrence Tabak, National Institutes of Health (NIH)
Members
- Gary Disbrow, Biomedical Advanced Research and Development Authority (BARDA)
- Mikael Dolsten, Pfizer
- Anthony Fauci, National Institute of Allergy and Infectious Diseases (NIAID)
- Gary Gibbons, National Heart, Lung, and Blood Institute (NHLBI)
- Peter Marks, U.S. Food and Drug Administration (FDA)
- Andrew Plump, Takeda
- Janet Woodcock, Operation Warp Speed (OWS)
ACTIV Working Groups
Preclinical Co-Chairs
- Christine Colvis, National Center for Advancing Translational Sciences (NCATS)
- John Young, Roche
Tracking Resistance and Coronavirus Evolution (TRACE) Co-Chairs
- Matthew Hall, National Center for Advancing Translational Sciences (NCATS)
- Lisa Purcell, Vir Biotechnology
Therapeutics Clinical Co-Chairs
- Ruxandra Draghia-Akli, Janssen Pharmaceuticals
- Sarah Read, National Institute of Allergy and Infectious Diseases (NIAID)
- Eric Hughes, Novartis
Clinical Trial Capacity Co-Chairs
- Elizabeth Desrosiers, Merck
- Michael Kurilla, National Center for Advancing Translational Sciences (NCATS)
Vaccines Co-Chairs
- Katherine Jansen, Pfizer
- Doug Lowy, National Cancer Institute (NCI)
Partners
Government
Industry
Not-For-Profit
Donate
Donate to the FNIH today to support medical research that saves lives
Partner With Us
Work with the FNIH to accelerate medical breakthroughs for patients